about
Role of immune escape mechanisms in Hodgkin's lymphoma development and progression: a whole new world with therapeutic implicationsControlling the HIV/AIDS epidemic: current status and global challengesRelationship between ambient ultraviolet radiation and Hodgkin lymphoma subtypes in the United StatesAge-period-cohort analysis of cancers not related to tobacco, screening, or HIV: sex and race differencesPathology of lymphoma in HIV.How do viruses trick B cells into becoming lymphomas?HLA-A*02:07 is a protective allele for EBV negative and a susceptibility allele for EBV positive classical Hodgkin lymphoma in ChinaRecent Advances in the Pathobiology of Hodgkin's Lymphoma: Potential Impact on Diagnostic, Predictive, and Therapeutic Strategies.Human Immunodeficiency Virus Infection and Hodgkin's Lymphoma in South Africa: An Emerging ProblemHIV and cancer in GermanyAge at cancer diagnosis among persons with AIDS in the United States.Effect of immune reconstitution on the incidence of HIV-related Hodgkin lymphomaDevelopment of diagnostic criteria for serious non-AIDS events in HIV clinical trials.HIV-associated Hodgkin lymphoma during the first months on combination antiretroviral therapy.Different time trends by gender for the incidence of Hodgkin's lymphoma among young adults in the USA: a birth cohort phenomenon.The role of viral co-infection in HIV-associated non-AIDS-related cancersThe extent of genetic diversity of Epstein-Barr virus and its geographic and disease patterns: a need for reappraisal.Viral epigenomes in human tumorigenesis.Classical Hodgkin's lymphoma arising in different host's conditions: pathobiology parameters, therapeutic options, and outcome.Gammaherpesvirus and lymphoproliferative disorders in immunocompromised patientsNon-AIDS-defining cancers among HIV-infected patients.Multiple infections and cancer: implications in epidemiology.Decision-making in the management of adult classical Hodgkin's lymphoma: determining the optimal treatment.The role of microRNAs in the pathogenesis of HIV-related lymphomas.KSHV-encoded vIL-6 collaborates with deregulated c-Myc to drive plasmablastic neoplasms in mice.The impact of EBV and HIV infection on the microenvironmental niche underlying Hodgkin lymphoma pathogenesis.Acute toxoplasmosis-etiological factor for development of Hodgkin's lymphoma?Survival and predictors of death in people with HIV-associated lymphoma compared to those with a diagnosis of lymphoma in general population.Clinical characteristics of human immunodeficiency virus-associated Hodgkin lymphoma patients in Japan.Primary bone marrow Hodgkin lymphoma in an HIV-negative patient.Interaction of viral oncogenic proteins with the Wnt signaling pathway
P2860
Q27011510-7EFF4053-5B45-448E-A07D-356E0F4CD0BCQ30420558-12235805-F5E5-4B90-9398-71A31F25428DQ30798647-1EE5E46B-2F67-4A9D-88D2-81646A59AA33Q33996387-5AD0F236-BF2A-4725-9003-2755E8619A59Q34020069-731FF203-CA8A-4DC0-8039-D491AA880C7EQ34020096-4DFB1F25-5D0E-4E17-9CDC-CD48202E7E5BQ34166497-CAF35B4F-C4F0-4144-A33E-4CD6B8A4B0B7Q34557179-31F6919B-5E2B-4153-8A03-5532F54310FBQ34571564-377059BE-341F-4B18-AEAC-0A41785776E3Q34660212-6264E1E2-4589-4A8B-BD1F-A7585D1BC763Q34766695-D3E13D9D-705F-4F5B-A4C6-53FDCD1CCDE3Q35009761-BF1FA243-74D0-42F3-88EC-DCFDA23CDD26Q35030752-A5B84E4A-CEA9-4C15-8E4E-BAD9A8F9FE7BQ35114512-DE532563-9DBC-493E-8E47-5D8595660124Q36832395-C2A940AE-C7B8-4B42-A639-724E3FC0311CQ36960884-38973ED5-D4A2-4FAB-9F0C-55A971952244Q37549340-7D40C72A-2784-4DDA-82C2-DE8A942E6975Q37681282-2585182E-CF23-4F16-8531-4B78B43D60C8Q37832198-73945D18-EB57-498F-AE3D-F0FAFB1357FFQ37865141-4BEAF118-CEAA-4212-9CA0-742D50B5F658Q38112573-902F0DDC-76F8-4154-8EE7-64064D5D69FAQ38126931-9F32C4C0-0A49-41C9-B0F1-EA99E323C9C3Q38337152-69EB1182-339A-429D-918C-FCD6EE8B2F3AQ38555990-4A4261B8-434B-4C10-B760-EF5FE64DE7F4Q38686974-ADBA7834-1A83-4992-B1D7-4208E92CB076Q38983067-E187B558-47F9-4C53-950F-244F685CF5D3Q42255386-500BB51C-EA3A-485F-8FE7-D3EDC2AC2A7BQ43077908-539ECBA1-FE6D-4212-8765-3A2BD1BC26B8Q45356450-DD5CA952-8D5F-439D-82F6-1B7AB4867532Q53079010-2A4ABC87-33EF-430C-8EC2-BEDF71B17B2CQ56476000-126BDAEB-C07E-4D12-807F-0401FBCFB431
P2860
description
2009 nî lūn-bûn
@nan
2009 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
name
HIV-associated Hodgkin lymphoma.
@ast
HIV-associated Hodgkin lymphoma.
@en
HIV-associated Hodgkin lymphoma.
@nl
type
label
HIV-associated Hodgkin lymphoma.
@ast
HIV-associated Hodgkin lymphoma.
@en
HIV-associated Hodgkin lymphoma.
@nl
prefLabel
HIV-associated Hodgkin lymphoma.
@ast
HIV-associated Hodgkin lymphoma.
@en
HIV-associated Hodgkin lymphoma.
@nl
P2093
P50
P1476
HIV-associated Hodgkin lymphoma
@en
P2093
Annunziata Gloghini
Antonino Carbone
Diego Serraino
Michele Spina
P356
10.1097/COH.0B013E32831A722B
P577
2009-01-01T00:00:00Z